PRESS RELEASE: IVI Releases 2022 Annual Report

Alexandria, VA – July 13, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, today announced the release of its 2022 Annual Report. The 2022 Annual Report highlights IVI’s key milestones and significant accomplishments across all aspects […]

IVI Responds to the ICER 2023 Value Assessment Framework

IVI submitted comments on the ICER 2023 Value Assessment Framework. We appreciate the opportunity to provide comments on this important issue. In revising its value assessment framework, IVI recommends that ICER make modifications related to proposed methodological changes, patient engagement strategies, and methods for handling data gaps to increase equity within health technology assessment. Read […]

PRESS RELEASE: IVI Submits Comments on FDA’s Patient-Focused Drug Development Program

Alexandria, VA – July 11, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in healthcare, submitted comments on the U.S. Food and Drug Administration’s (FDA) Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision-Making Guidance […]

IVI Announces Leadership Update

It is with mixed emotions we announce that Jennifer Bright, MPA, will be stepping down from her position as Chief Strategy and Engagement Officer effective June 30th. Ms. Bright joined IVI in 2017 and served as the organization’s first Executive Director and then Chief Executive Officer until July 2022, when she transitioned into her current […]

Bringing One Health Journey Forward: An Interview with Shannan O’Hara-Levi about the Economic Impacts of Rheumatoid Arthritis

In 2021, the Innovation and Value Initiative (IVI) and the Arthritis Foundation published a report, First Hand Perspectives in Rheumatoid Arthritis, describing how researchers often miss the priorities and needs of people living with rheumatoid arthritis (RA). Each of the patient-advocate co-authors reiterated that the costs related to RA reach far beyond direct medical costs, […]

PRESS RELEASE: IVI and AcademyHealth Release Economic Impacts Framework

Alexandria, VA – June 7, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment in healthcare, in partnership with AcademyHealth, released a joint report, “A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers,” for […]

IVI Partners with AcademyHealth to Address Economic Impacts on Patients and Caregivers

IVI, in partnership with AcademyHealth, released a joint report, “A Research Framework to Understand the Full Range of Economic Impacts on Patients and Caregivers,” for researchers, value assessors, and other decision-makers to address the full range of economic impacts on patients. This report was made possible through funding support from the Eugene Washington PCORI Engagement […]

IVI MEMBER SPOTLIGHT: Richard Seiden, JD

Richard Seiden, retired attorney and patient advocate, is a member of the IVI Patient Advisory Council, where he provides valuable insight into IVI’s work. In a recent conversation, Richard shared how psoriatic arthritis has impacted his life and why he works with IVI to center the patient within the health technology assessment process. Richard, thank […]

PRESS RELEASE: Non-Profit Research Organization Makes Patient-Centered Recommendations to CMS for Medicare DPNP

Alexandria, VA – May 5, 2023 – The Innovation and Value Initiative (IVI), a non-profit research organization committed to advancing the science, practice, and use of health technology assessment (HTA) in health care, submitted comments on the Centers for Medicare & Medicaid Services (CMS) initial guidance on the implementation of the Medicare Drug Price Negotiation Program (Medicare […]